17th Oct 2014 10:03
LONDON (Alliance News) - GlaxoSmithKline PLC has said its Ebola vaccine will "come too late" for the current epidemic, the BBC reported on Friday.
Ripley Ballou, the head of the FTSE 100 pharmaceuticals group's Ebola vaccine research team, said full data on the safety and efficacy of its Ebola drug would not be ready until late 2015.
Glaxo is one of a number of companies attempting to fast-track a vaccine for the disease as the death tolls mounts in West Africa and as cases start to appear in Europe and the US.
http://www.bbc.co.uk/news/health-29649572
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline